Guardian Pharmacy Services, Inc. (GRDN) Stock

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. (GRDN) stock trades at $39.44 with a market capitalization of $2.50B. The stock is valued at a price-to-earnings (P/E) ratio of 40.36, price-to-book of 10.93, price-to-sales of 1.83. Over the past 52 weeks the stock has ranged between $23.14 and $48.33, and currently trades 18.4% below its 52-week high.

On profitability, Guardian Pharmacy Services, Inc. generates a return on equity (ROE) of 30.80%, above the typical market range of roughly 12-15%, return on capital employed of 31.69%, an operating margin of 5.04%, a net profit margin of 4.50%.

Guardian Pharmacy Services, Inc. by the numbers, 2018–2025

Between 2018 and 2025 Guardian Pharmacy Services, Inc. reported revenue of $600.0M rising to $1.4B, a change of +141.5% across 8 years. Compounded, revenue has grown 14.5% a year over five years, 16.8% over three, 18.0% over the last twelve months. Net profit rose to $49.0M.

Operating margin went from 4.3% in 2018 to 6.1% in 2025, a gain of 1.8 percentage points. The most recent net margin is 4.50%. On a trailing twelve-month basis to Jun '26, revenue is $1.5B and net profit $66.0M.

Borrowings fell from $44.0M to $37.0M, cash from operations was $100.0M in the latest year, positive in 8 of the last 8.

Return on equity has averaged 39.4% over five years, and was 23.8% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Guardian Pharmacy Services, Inc. (GRDN) — frequently asked questions